Scientific work

Doç. Dr. Doğan Yazılıtaş

101 publications. The source of the information is stated next to each publication.

Back to profile

  1. Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer

    Journal of Cancer Research and Clinical Oncology, 2012

    DOI 10.1007/s00432-012-1296-x PMID 22878681 11 citations (Europe PMC) Open-access full textSource: ORCID